環亞國際醫療(1143.HK)暴跌超60%
格隆匯5月24日丨環亞國際醫療(1143.HK)上午盤中閃崩一度暴跌61%報0.51港元,目前跌幅仍維持在56%左右,暫成交3011萬港元,市值已不到3億港元。公司曾自2月初啟動上漲行情,一路由0.345港元漲至4月底的逼近2港元,隨後明顯回落。消息面上,公司19日晚間還發布公吿稱透過全資子公司環亞輔助生殖科技與福建諾醫可訂立不具法律約束力的合資合作備忘錄,有意向組建合資公司,擬搭建“輔助生殖+醫療美容”消費醫療服務及相關產品的市場營銷、推廣渠道體系。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.